Obeticholic Acid Tablets (5 mg, 10 mg)
Obeticholic Acid is a selective farnesoid X receptor (FXR) agonist that modulates bile acid synthesis, secretion, and reabsorption, while reducing hepatic inflammation. It was the first targeted therapy developed for primary biliary cholangitis in over two decades.
Indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
Disclaimer
The content on this website is for general informational purposes only. While we strive for accuracy, RV Group makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.
Our Obeticholic Acid Tablets (5 mg, 10 mg) are also Available for
FAQ on Obeticholic Acid Tablets (5 mg, 10 mg)
Everything You Need to Know About RV Groups
RV Group operates through four integrated business verticals, each designed to create value across the pharmaceutical ecosystem.
Our Business
Quick Links
Contact
- hello@opv.vn
- +1 800 555 25 65